We hear a lot about antioxidants. Vitamin C. Vitamin E. Polyphenols. They appear on food labels, supplement shelves, and skincare packaging.
Less discussed is the fact that the human body actively absorbs and stores one antioxidant most people have never heard of, concentrating it in specific tissues rather than letting it simply pass through. Its name is ergothioneine.
It hasn’t emerged as a wellness trend, nor does it promise quick results. The body can’t make it on its own. What makes it interesting isn’t hype, but biology. The body treats it differently from many other dietary compounds. That difference raises a simple question: why does the body hold on to it?
An antioxidant the body actively absorbs
Most antioxidants move through the body passively. Ergothioneine doesn’t.
Humans have a dedicated transporter protein that moves ergothioneine from food into the bloodstream and deliver it to specific organs. These include the brain, liver, kidneys, eyes, and bone marrow, tissues that are metabolically active and routinely exposed to oxidative and inflammatory stress.
This is unusual. The body doesn’t maintain specialised transport systems without reason. Researchers see this pattern as a sign that ergothioneine may support cells that face constant wear.
This doesn’t mean ergothioneine prevents disease. It simply suggests the body considers it worth conserving.
Ergothioneine is often described as a “unique” antioxidant, not because it’s more potent than vitamin C or vitamin E, but because the body appears to handle it differently, Dr May-Zhang, a translational scientist who specialises in functional ingredients for healthspan, explains. Humans can’t synthesise ergothioneine, yet the body has a dedicated transporter, OCTN1 (also known as the ergothioneine transporter, ETT), that actively moves it into tissues and supports long-term retention. This transporter-guided uptake and tissue accumulation are unusual among dietary antioxidants and suggest ergothioneine may play a meaningful physiological role, even though it can’t be formally classified as a vitamin because no clear deficiency disease has been identified.
By comparison, vitamin E is a true vitamin and, as a fat-soluble nutrient, is primarily located within lipid membranes and lipoproteins, where it helps prevent lipid peroxidation. Vitamin C is also an essential vitamin and is water-soluble, with well-established roles as an enzyme cofactor. While vitamin C can neutralise reactive species, many human studies show mixed effects on systemic markers of oxidative damage, and benefits may be more apparent in individuals with lower vitamin C status.
Ergothioneine occupies a slightly different category. It can interact with specific reactive oxygen species and bind redox-active metals, but the most conservative interpretation of current evidence is that it may function as an “adaptive” cytoprotectant, meaning its protective role may become more important when the body is under higher oxidative or inflammatory stress, rather than serving as a primary, everyday antioxidant defence in healthy individuals, Dr May-Zhang adds.
Vitamins C and E are essential nutrients with established deficiency syndromes. Ergothioneine, by contrast, has been described by some researchers as a “longevity vitamin.” Emerging observational studies link lower dietary intake or status of ergothioneine with less favourable ageing-related outcomes. This combination of unique biological handling and growing evidence related to healthspan is why ergothioneine has attracted increasing scientific interest as a potential longevity-associated nutrient.
How to visualise the transporter concept
Most dietary compounds circulate broadly once absorbed. Ergothioneine behaves differently. It’s more like a passenger with a reserved seat and a direct route.
Once inside cells, ergothioneine tends to remain rather than being rapidly broken down or excreted.
This contrast between general circulation and targeted uptake helps explain why ergothioneine is repeatedly found in organs such as the brain and bone marrow, while many other antioxidants move in and out with little persistence.
What sets ergothioneine apart
Many antioxidants neutralise free radicals and are then broken down or cleared. Ergothioneine behaves differently.
It’s unusually stable. It resists degradation from heat, light, and normal metabolic processes, and it doesn’t easily become pro-oxidant after neutralising oxidative stress. Instead of acting once and disappearing, it tends to remain inside cells.
Researchers believe it may help protect DNA, proteins, and mitochondria from cumulative oxidative damage. Interest has shifted toward its possible role in cellular resilience rather than short-term effects people can feel.
Because humans can’t synthesise ergothioneine, we depend entirely on dietary sources. Mushrooms are the richest source, although levels vary widely by species. Common white or brown button mushrooms (including cremini) and portobello tend to contain lower amounts, while oyster, shiitake, and porcini mushrooms are typically much higher.
What makes ergothioneine especially interesting is how the body handles it. Rather than relying on passive diffusion, ergothioneine is absorbed in the intestine through a specific transporter (often referred to as the ergothioneine transporter, OCTN1/ETT). After absorption, it circulates in the bloodstream and is then taken up and retained by cells and tissues that also express OCTN1, which may contribute to relatively sustained tissues levels compared to other water-soluble compounds.
Human supplementation studies further support this pattern. Only a small fraction of ingested ergothioneine appears in urine, suggesting it’s largely absorbed and retained rather than quickly excreted. Consistent with this, blood levels remain elevated for weeks after supplementation stops, before gradually returning toward baseline.
Why researchers are paying attention
Interest in ergothioneine has grown alongside research into ageing, neurodegeneration, and chronic inflammation, areas where damage accumulates gradually.
Population studies have observed associations between higher dietary ergothioneine intake and:
- lower markers of chronic inflammation
- reduced oxidative stress
- better cognitive and cardiovascular outcomes in older adults
These findings don’t establish cause and effect. They point to a relationship between intake and makers of cellular stress. For that reason, some researchers describe ergothioneine as “longevity-linked”, not because it extends lifespan, but because it may relate to how cells cope with wear over time.
Ergothioneine is often reported to accumulate in tissues that are frequently exposed to higher oxidative stress, consistent with its proposed cyroprotective role. Dr May-Zhang notes that both ergothioneine and its dedicated transporter are widely distributed throughout the body. Relatively high levels have been measured in whole blood, including red blood cells, as well as in organs such as the liver and kidneys, and in tissues including the spleen, lungs, heart, intestines, eyes, muscles, and brain.
This distribution pattern suggests that ergothioneine is actively taken up and retained in key tissues, rather than being passively present in circulation. It points to a potential role as a reserve cytoprotectant that becomes more relevant when oxidative or inflammatory stress is higher. Many of these tissues face high metabolic demand or ongoing oxidative exposure, and ergothioneine’s presence in these areas is consistent with a role in cellular defence and long-term health maintenance, helping to limit cumulative damage to biomolecules such as lipids, proteins, and DNA over time.
Why most people have never heard of it
Ergothioneine sits outside how nutrition is usually discussed. There’s no recognised deficiency state. You don’t feel suddenly unwell without it. Its absence doesn’t produce immediate symptoms. Because it doesn’t generate short-term feedback, it rarely enters everyday health decisions. For that reason, it has remained largely absent from public-facing conversations, despite growing scientific interest.
Based on existing evidence, Dr May-Zhang emphasises that healthcare professionals should present ergothioneine as a promising natural nutrient for healthy ageing, supported so far by observational studies and early clinical research. The key is to communicate with measured optimism, recognising its potential while being clear that it’s not a cure-all and not a replacement for foundational nutrition and lifestyle factors.
Several high-priority research questions still need to be addressed. These include what level of intake or biological status should be considered adequate, and how low status is best defined. It also remains unclear which populations are most likely to benefit, such as older adults, individuals under higher physiological stress, or those with consistently low mushroom intake. Other open questions relate to which outcomes are most responsive, including cognition, cardiometabolic health, and markers of inflammation or oxidative stress, as well as the long-term safety and effectiveness of ergothioneine across broader and more diverse populations. Finally, there is a need for better biomarkers and more standardised methods to assess ergothioneine status and biological response.
Should this change how we think about supplements?
Ergothioneine is present in foods that already support health in broader ways. Mushrooms provide fibre, beta-glucans, and a range of micronutrients that function together rather than in isolation.
For most people, the more relevant question isn’t about supplementation, but dietary variety. Nutrients like ergothioneine rarely produce noticeable effects in the short term. Their relevance becomes clearer through consistent intake over years.
As ergothioneine supplements become more widely available, current evidence suggests the field is promising but still evolving. Multiple observational studies have linked lower dietary intake or lower blood levels of ergothioneine with less favourable ageing-related outcomes, indicating that ergothioneine status may matter for long-term health.
Interventional evidence is also beginning to emerge. Randomised, placebo-controlled trials in healthy older adults using daily doses in the 10–25 mg range over 16 weeks have examined outcomes such as cognitive performance, subjective memory, and sleep-related measures. Some of these studies have reported favourable trends, including improvements in composite memory scores, subjective memory, and the ability to fall asleep, compared with baseline and, in some cases, placebo. Another study involving older adults with mild cognitive impairment, using 25 mg three times per week over one year, reported improvements in learning ability and a prevention of increases in a neurodegeneration-related biomarker. In addition, sleep-focused trials using 8 mg or 20 mg daily have shown encouraging results in selected subjective sleep measures.
However, several uncertainties remain. These include the optimal dose for different health goals, who is most likely to benefit (such as individuals with low baseline status or higher levels of physiological stress), how durable the effects are with longer-term use, and how supplementation compares with, or adds to, food-based intake patterns, particularly diets rich in mushrooms.
From a practical perspective, supplementation may be reasonable for individuals with consistently low dietary intake, such as those who rarely consume mushrooms. The most responsible interpretation of the evidence is to prioritise quality and transparency, keep expectations realistic, and recognise that clearer guidance will depend on larger, longer-term trials across more diverse populations.
How this changes shape the way we think about food
Ergothioneine sits outside how nutrition is usually framed. There’s no daily target and no immediate signal when it’s absent. Its significance becomes clearer when health is considered across years rather than days.
That perspective shifts attention away from reacting to symptoms and toward how ordinary food choices, repeated consistently, shape resilience. Some influences on health aren’t felt in the moment They reveal themselves gradually, in how well the body holds up over time.
Dr Linda May-Zhang, PhD
Vice President of Science & Innovation
Blue California, USA
LinkedIn: Blue California Ingredients
This article was produced by Healthful For You. The views and opinions expressed throughout are those of the authors and do not necessarily reflect those of the Expert Contributor. The Expert Contributor has provided input solely for the EXPERT INSIGHT and TIP segments, based on their professional expertise. These comments are intended to offer general guidance and may not apply to all individuals. Any interpretations or conclusions beyond that section are those of Healthful For You. This article is not a substitute for personalised medical advice, diagnosis, or treatment. Please consult your doctor or a healthcare professional regarding your specific health needs.
We hope you found this article informative. Healthful For You welcomes contributions from healthcare professionals, patients, and community members. If you have a story, research, or a perspective that can enrich our dialogue, please get in touch with us at [email protected].